2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Stock Value | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | NA | NA | |
Weighted Average Number Of Diluted Shares Outstanding | 474.86 | 462.25 | NA | 453.41 | 449.90 | 446.51 | NA | 426.59 | 406.89 | 168.19 | NA | NA | NA | NA | |
Weighted Average Number Of Shares Outstanding Basic | 474.86 | 462.25 | NA | 453.41 | 449.90 | 446.51 | NA | 426.59 | 406.89 | 168.19 | NA | NA | NA | NA | |
Earnings Per Share Basic And Diluted | NA | NA | NA | NA | NA | NA | -0.16 | -0.21 | -0.04 | -0.25 | -0.61 | -0.46 | 0.00 | -0.38 | |
Income Loss From Continuing Operations Per Basic Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | NA | NA | NA | NA | |
Income Loss From Continuing Operations Per Diluted Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | NA | NA | NA | NA |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Including Assessed Tax | 50.00 | 60.86 | 92.38 | 66.94 | 75.66 | 64.51 | 100.56 | 56.89 | 55.20 | 59.24 | 88.58 | 55.48 | 51.80 | 48.06 | |
Revenues | 50.00 | 60.86 | 92.38 | 66.94 | 75.66 | 64.51 | 100.56 | 56.89 | 55.20 | 59.24 | 88.58 | 55.48 | 51.80 | 48.06 | |
Cost Of Revenue | 28.27 | 30.18 | 52.40 | 36.19 | 37.39 | 39.02 | 53.50 | 29.63 | 27.28 | 28.54 | 44.05 | 30.09 | 27.21 | 25.56 | |
Gross Profit | 21.73 | 30.68 | 39.98 | 30.75 | 38.27 | 25.49 | 47.06 | 27.26 | 27.93 | 30.70 | 44.53 | 25.39 | 24.59 | 22.49 | |
Operating Expenses | 100.86 | 139.94 | 109.26 | 127.85 | 106.31 | 115.09 | 116.51 | 123.96 | 74.38 | 72.25 | 111.61 | 70.53 | 60.85 | 59.22 | |
Research And Development Expense | 54.59 | 62.33 | 60.72 | 57.27 | 52.60 | 52.01 | 50.32 | 50.30 | 44.52 | 44.23 | 45.60 | 41.68 | 38.20 | 34.37 | |
General And Administrative Expense | 25.29 | 50.74 | 26.76 | 30.70 | 28.88 | 29.64 | 36.84 | 31.69 | 16.26 | 12.60 | 54.05 | 16.59 | 14.31 | 14.19 | |
Selling And Marketing Expense | 18.33 | 22.66 | 21.78 | 39.88 | 24.84 | 33.43 | 29.35 | 41.98 | 13.59 | 15.42 | 11.96 | 12.26 | 8.33 | 10.65 | |
Litigation Settlement Expense | 0.10 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Operating Income Loss | -79.13 | -109.26 | -69.27 | -97.10 | -68.04 | -89.60 | -69.45 | -96.70 | -46.45 | -41.55 | -2.67 | -45.14 | -36.25 | -36.72 | |
Interest Income Expense Net | 3.75 | 4.31 | 4.37 | 3.67 | 1.39 | 0.24 | 0.06 | 0.08 | 0.09 | 0.04 | 0.06 | 0.05 | 0.07 | 0.07 | |
Allocated Share Based Compensation Expense | 23.74 | 51.10 | NA | NA | 28.97 | 30.46 | 20.46 | 17.41 | 10.43 | 9.64 | 51.20 | 14.99 | 10.80 | 9.70 | |
Income Tax Expense Benefit | 0.04 | NA | -0.63 | -0.61 | 1.27 | -0.25 | 0.03 | -3.51 | NA | NA | NA | NA | NA | NA | |
Profit Loss | -75.27 | -104.62 | -64.10 | -91.96 | -66.06 | -89.53 | -69.54 | -89.40 | -16.52 | -42.03 | -67.01 | -44.65 | -36.19 | -35.77 | |
Other Comprehensive Income Loss Net Of Tax | 0.95 | -0.33 | -0.31 | -1.94 | 0.83 | 0.62 | 0.21 | -0.04 | NA | NA | NA | NA | NA | NA | |
Net Income Loss | -75.27 | -104.62 | -64.10 | -91.96 | -66.06 | -89.53 | -69.54 | -89.40 | -16.52 | -42.03 | 23.30 | -44.65 | -0.00 | -0.00 | |
Comprehensive Income Net Of Tax | -74.32 | -104.96 | -64.41 | -93.90 | -65.24 | -88.91 | -69.33 | -89.43 | -16.52 | -42.03 | -67.01 | -44.65 | NA | NA |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | 801.23 | 871.20 | 942.60 | 1024.65 | 1040.73 | 1062.23 | 1152.07 | 1226.32 | 903.04 | 947.02 | 509.19 | 509.88 | NA | NA | |
Liabilities | 175.98 | 195.71 | 228.66 | 273.66 | 221.41 | 208.03 | 236.41 | 265.14 | 243.53 | 284.48 | 64.13 | 88.12 | NA | NA | |
Liabilities And Stockholders Equity | 801.23 | 871.20 | 942.60 | 1024.65 | 1040.73 | 1062.23 | 1152.07 | 1226.32 | 903.04 | 947.02 | 509.19 | 509.88 | NA | NA | |
Stockholders Equity | 625.25 | 675.49 | 713.94 | 750.99 | 819.32 | 854.20 | 915.66 | 961.17 | 659.51 | 662.54 | 5.00 | 5.00 | 0.01 | 0.01 |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | 298.00 | 360.28 | 424.99 | 508.67 | 506.20 | 519.81 | 601.79 | 669.86 | 769.38 | 814.66 | 0.46 | 1.24 | NA | NA | |
Cash | 256.39 | 314.35 | 386.85 | 432.80 | 410.89 | 479.40 | 553.18 | 586.20 | 701.05 | 769.94 | 282.49 | 288.69 | 177.11 | 172.12 | |
Cash And Cash Equivalents At Carrying Value | 256.39 | 314.35 | 386.85 | 432.80 | 410.89 | 479.40 | 553.18 | 586.20 | 701.05 | 769.94 | 0.08 | 0.79 | 0.02 | NA | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 264.76 | 322.72 | 395.22 | 441.17 | 419.46 | 487.97 | 561.75 | 594.78 | 709.42 | 778.31 | 290.86 | 297.06 | 185.48 | 180.49 | |
Accounts Receivable Net Current | 1.50 | 4.12 | 1.90 | 26.81 | 52.88 | 2.92 | 3.38 | 23.56 | 26.71 | 9.40 | 2.48 | NA | NA | NA | |
Inventory Net | 14.98 | 11.81 | 10.25 | 11.96 | 13.81 | 11.46 | 10.79 | 17.13 | 17.73 | 15.27 | 6.24 | NA | NA | NA | |
Prepaid Expense And Other Assets Current | 17.95 | 21.29 | 19.22 | 21.37 | 20.24 | 17.88 | 25.14 | 25.25 | 16.96 | 12.53 | 15.48 | NA | NA | NA |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Property Plant And Equipment Gross | 113.57 | 113.47 | 113.92 | 112.97 | 113.89 | 113.14 | 112.47 | 111.07 | 110.16 | 112.12 | 111.21 | NA | NA | NA | |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 80.76 | 77.76 | 75.32 | 72.18 | 69.84 | 66.23 | 62.62 | 58.82 | 56.41 | 54.42 | 50.33 | NA | NA | NA | |
Amortization Of Intangible Assets | 3.80 | 3.80 | 3.90 | 4.50 | 4.50 | 4.50 | 4.60 | 3.00 | NA | NA | NA | NA | NA | NA | |
Property Plant And Equipment Net | 32.80 | 35.70 | 38.61 | 40.79 | 44.06 | 46.91 | 49.85 | 52.25 | 53.75 | 57.70 | 60.88 | NA | NA | NA | |
Goodwill | 351.74 | 351.74 | 351.74 | 351.74 | 351.74 | 351.74 | 351.74 | 351.60 | NA | NA | NA | NA | NA | NA | |
Indefinite Lived Intangible Assets Excluding Goodwill | 37.84 | 41.68 | 45.52 | 49.36 | 64.93 | 69.39 | 73.91 | 78.46 | NA | NA | NA | NA | NA | NA | |
Finite Lived Intangible Assets Net | 37.84 | 41.68 | 45.52 | 49.36 | 64.93 | 69.39 | 73.91 | 78.46 | NA | NA | NA | NA | NA | NA | |
Other Assets Noncurrent | 2.36 | 2.61 | 3.02 | 3.30 | 3.43 | 3.36 | 2.59 | 1.38 | 6.81 | 0.55 | 0.65 | NA | NA | NA |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liabilities Current | 101.60 | 118.91 | 149.42 | 200.11 | 144.91 | 127.81 | 153.24 | 179.55 | 113.63 | 122.67 | 121.62 | NA | NA | NA | |
Accounts Payable Current | 8.55 | 12.75 | 12.92 | 13.98 | 10.55 | 18.05 | 37.93 | 14.42 | 10.28 | 17.68 | 12.27 | NA | NA | NA | |
Accrued Liabilities Current | 44.69 | 50.22 | 66.43 | 69.04 | 44.42 | 52.04 | 44.59 | 46.30 | 29.54 | 33.03 | 1.63 | 0.03 | NA | NA |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Liabilities Noncurrent | 1.42 | 1.39 | 1.48 | 2.11 | 2.64 | 3.98 | 4.65 | 4.76 | 1.21 | 1.19 | 1.17 | NA | NA | NA | |
Operating Lease Liability Noncurrent | 72.96 | 75.41 | 77.76 | 71.44 | 73.87 | 76.24 | 78.52 | 80.83 | 82.57 | 84.67 | 87.58 | NA | NA | NA |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stockholders Equity | 625.25 | 675.49 | 713.94 | 750.99 | 819.32 | 854.20 | 915.66 | 961.17 | 659.51 | 662.54 | 5.00 | 5.00 | 0.01 | 0.01 | |
Common Stock Value | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | NA | NA | |
Additional Paid In Capital Common Stock | 2311.48 | 2287.41 | 2220.90 | 2193.54 | 2167.97 | 2137.61 | 2110.16 | 2086.35 | 1695.26 | 1681.77 | 381.62 | NA | NA | NA | |
Retained Earnings Accumulated Deficit | -1686.28 | -1611.01 | -1506.38 | -1442.29 | -1350.33 | -1284.26 | -1194.73 | -1125.18 | -1035.79 | -1019.26 | -25.31 | -48.60 | NA | NA | |
Accumulated Other Comprehensive Income Loss Net Of Tax | NA | -0.95 | -0.62 | -0.31 | 1.63 | 0.80 | 0.18 | -0.04 | NA | NA | NA | NA | NA | NA |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -57.12 | -69.36 | -44.96 | 25.55 | -72.93 | -73.04 | -35.20 | -24.60 | -62.49 | -44.53 | -40.27 | 28.43 | -29.51 | -32.91 | |
Net Cash Provided By Used In Investing Activities | -2.77 | -2.69 | -3.29 | -3.07 | -2.05 | -2.90 | -3.20 | -95.82 | -7.73 | -1.39 | -0.79 | -0.74 | -1.05 | -3.95 | |
Net Cash Provided By Used In Financing Activities | 1.59 | -0.11 | 2.61 | -0.01 | 5.65 | 1.53 | 5.52 | 5.78 | 1.33 | 533.37 | 0.30 | 83.89 | 35.56 | 1.03 |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -57.12 | -69.36 | -44.96 | 25.55 | -72.93 | -73.04 | -35.20 | -24.60 | -62.49 | -44.53 | -40.27 | 28.43 | -29.51 | -32.91 | |
Net Income Loss | -75.27 | -104.62 | -64.10 | -91.96 | -66.06 | -89.53 | -69.54 | -89.40 | -16.52 | -42.03 | 23.30 | -44.65 | -0.00 | -0.00 | |
Profit Loss | -75.27 | -104.62 | -64.10 | -91.96 | -66.06 | -89.53 | -69.54 | -89.40 | -16.52 | -42.03 | -67.01 | -44.65 | -36.19 | -35.77 | |
Increase Decrease In Accounts Receivable | -2.62 | 2.23 | -24.91 | -26.07 | 49.96 | -0.46 | -20.18 | -3.15 | 31.15 | -6.92 | -2.65 | -21.50 | 18.36 | 1.88 | |
Increase Decrease In Inventories | 3.17 | 1.57 | -1.71 | -1.84 | 2.34 | 0.67 | -6.34 | -0.89 | 20.53 | -9.03 | -10.01 | 3.78 | -4.50 | 2.85 | |
Increase Decrease In Accounts Payable | -3.95 | -0.00 | -1.27 | 3.66 | -7.81 | -19.15 | 23.66 | 0.19 | -6.72 | 5.72 | 0.35 | 3.99 | 2.52 | -6.72 | |
Deferred Income Tax Expense Benefit | NA | NA | -4.90 | 0.60 | 1.30 | 0.30 | 0.00 | 3.50 | NA | NA | 0.00 | NA | NA | NA | |
Share Based Compensation | 23.74 | 51.10 | 22.25 | 34.34 | 28.97 | 30.46 | 20.46 | 17.41 | 10.43 | 9.64 | 51.20 | 14.99 | 10.87 | 11.36 |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | -2.77 | -2.69 | -3.29 | -3.07 | -2.05 | -2.90 | -3.20 | -95.82 | -7.73 | -1.39 | -0.79 | -0.74 | -1.05 | -3.95 | |
Payments To Acquire Property Plant And Equipment | 0.30 | 0.42 | 1.19 | 0.91 | 0.33 | 1.61 | 1.55 | 0.61 | 1.14 | 0.67 | 0.19 | 0.23 | 0.09 | 3.54 |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | 1.59 | -0.11 | 2.61 | -0.01 | 5.65 | 1.53 | 5.52 | 5.78 | 1.33 | 533.37 | 0.30 | 83.89 | 35.56 | 1.03 |
2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 50.00 | 60.86 | 92.38 | 66.94 | 75.66 | 64.51 | 100.56 | 56.89 | 55.20 | 59.24 | 88.58 | 55.48 | 51.80 | 48.06 | |
Lemonaid Health Inc | NA | NA | NA | NA | NA | NA | 11.50 | NA | NA | NA | NA | NA | NA | NA | |
Variable Interest Entities | 8.50 | 9.00 | 9.10 | 10.00 | 10.40 | 10.70 | 11.80 | 7.60 | NA | NA | NA | NA | NA | NA | |
Consolidated Entity Excluding Vie | NA | NA | NA | NA | 10.40 | 10.70 | 11.80 | 7.60 | NA | NA | NA | NA | NA | NA | |
Consumer And Research Services, Sales Revenue Net, Customer Concentration Risk, Customer B | 1.08 | 10.67 | 11.19 | 13.07 | 14.93 | 8.25 | 16.78 | 8.07 | NA | NA | NA | NA | NA | NA | |
Consumer And Research Services, Sales Revenue Net, Customer Concentration Risk, Customer C | 13.04 | 9.71 | 24.36 | 14.68 | 17.06 | 9.63 | 20.75 | 9.68 | NA | NA | NA | NA | NA | NA | |
Consumer And Research Services, Customer B | NA | NA | NA | NA | 14.93 | 8.25 | 16.78 | 8.07 | 10.00 | 11.21 | 9.70 | 8.55 | 9.84 | 11.83 | |
Consumer And Research Services, Customer C | NA | NA | NA | NA | 17.06 | 9.63 | 20.75 | 9.68 | 14.94 | 8.51 | 19.82 | 17.45 | 6.84 | 5.85 | |
Consumer And Research Services | 50.00 | 60.86 | 92.38 | 66.94 | 75.66 | 64.51 | 100.56 | 56.89 | 55.20 | 59.24 | 88.58 | 55.48 | 51.80 | 48.01 | |
Therapeutics | NA | NA | NA | 66.94 | 75.66 | NA | NA | 56.89 | 55.20 | NA | 0.01 | 0.00 | 0.00 | 0.05 | |
Revenue From Contract With Customer Including Assessed Tax | 50.00 | 60.86 | 92.38 | 66.94 | 75.66 | 64.51 | 100.56 | 56.89 | 55.20 | 59.24 | 88.58 | 55.48 | 51.80 | 48.06 | |
Consumer Services | 48.66 | 47.55 | 80.92 | 53.64 | 56.51 | 56.06 | 83.51 | 46.04 | 44.49 | 47.85 | 78.14 | 44.09 | 40.56 | 34.73 | |
Pgs | 39.60 | 37.03 | 70.80 | 42.60 | 44.84 | 44.17 | 71.98 | 38.37 | 44.49 | 47.85 | 78.14 | 44.09 | NA | NA | |
Research Services | 1.34 | 10.96 | 11.45 | 13.30 | 19.15 | 8.45 | 17.05 | 10.85 | 10.72 | 11.39 | 10.43 | 11.38 | 11.25 | 13.28 | |
Health Care Other | 9.06 | 10.52 | 10.13 | 11.04 | 11.67 | 11.88 | 11.53 | 7.67 | NA | NA | NA | NA | NA | NA | |
Service | 50.00 | 60.86 | 92.38 | 66.94 | 75.66 | 64.51 | 100.56 | 56.89 | 55.20 | 59.24 | 88.58 | 55.48 | 51.80 | NA | |
Consumer Services, Transferred At Point In Time | 41.07 | 40.04 | 73.40 | 46.09 | 49.28 | 49.05 | 77.34 | 41.24 | 41.40 | 45.02 | NA | NA | NA | NA | |
Consumer Services, Transferred Over Time | 7.58 | 7.51 | 7.52 | 7.55 | 7.23 | 7.01 | 6.17 | 4.80 | 3.08 | 2.83 | NA | NA | NA | NA | |
Pgs, Transferred At Point In Time | 34.20 | 31.76 | 65.57 | 37.50 | 40.11 | 39.69 | 68.19 | 35.09 | 41.40 | 45.02 | NA | NA | NA | NA | |
Pgs, Transferred Over Time | 5.40 | 5.27 | 5.23 | 5.10 | 4.73 | 4.48 | 3.79 | 3.28 | 3.08 | 2.83 | NA | NA | NA | NA | |
Research Services, Transferred At Point In Time | 0.00 | 2.35 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Research Services, Transferred Over Time | 1.34 | 13.31 | 11.45 | 13.30 | 19.15 | 8.45 | 17.05 | 10.85 | 10.72 | 11.39 | NA | NA | NA | NA | |
Health Care Other, Transferred At Point In Time | 6.87 | 8.29 | 27.49 | 2.45 | 9.17 | 9.36 | 13.77 | 1.53 | NA | NA | NA | NA | NA | NA | |
Health Care Other, Transferred Over Time | 2.18 | 2.24 | -17.36 | 8.59 | 2.50 | 2.52 | -2.24 | 6.15 | NA | NA | NA | NA | NA | NA | |
Service, Transferred At Point In Time | 41.07 | 42.40 | 73.40 | 46.09 | 49.28 | 49.05 | 77.34 | 41.24 | 41.40 | 45.02 | NA | NA | NA | NA | |
Service, Transferred Over Time | 8.93 | 18.47 | 18.97 | 20.85 | 26.38 | 15.46 | 23.22 | 15.65 | 13.80 | 14.22 | NA | NA | NA | NA | |
2.56 | 2.17 | 4.84 | 2.87 | 2.84 | 3.04 | 5.24 | 3.06 | 2.75 | 3.24 | 4.89 | 3.33 | 2.34 | 1.61 | ||
4.16 | 14.36 | 15.82 | 16.19 | 19.03 | 11.97 | 21.46 | 10.78 | 12.34 | 13.91 | 13.68 | 10.72 | 11.77 | 13.21 | ||
US | 42.19 | 43.33 | 69.82 | 46.77 | 52.55 | 48.11 | 71.73 | 41.74 | 38.61 | 40.35 | 67.62 | 40.07 | 36.07 | 32.36 | |
International | NA | NA | NA | NA | 23.11 | 16.41 | 28.83 | 15.15 | 16.59 | 18.89 | 20.96 | 15.40 | 15.74 | 15.70 | |
Other Regions | 1.09 | 1.01 | 1.90 | 1.11 | 1.24 | 1.39 | 2.13 | 1.31 | 1.51 | 1.74 | 2.39 | 1.35 | 1.63 | 0.87 | |
GSK | 1.10 | 10.70 | 11.10 | 13.10 | 14.90 | 8.30 | 16.80 | 8.10 | 10.00 | 11.20 | 9.70 | 8.60 | 9.80 | 11.80 |